Medicure Announces Completion of Enrollment in Its MEND-PNPO Phase 3 Clinical Trial

Stock Information for Medicure Inc.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Medicure Inc.

Medicure Announces Grant of Stock Options
Medicure Presents MEND-PNPO Phase 3 Study Design and Baseline Data at the 16th European Epilepsy Congress
Medicure Reports Financial Results for Quarter Ended June 30, 2026 and Schedules August 17, 2026 Conference Call
Medicure Announces CFO Change
Medicure Announces AGM Results and Appointment of New Director
Medicure Reports Financial Results for Quarter Ended March 31, 2026 and Schedules May 25, 2026 Conference Call
Medicure Reports Financial Results for the Year Ended December 31, 2025 and Schedules April 27, 2026 Conference Call
Medicure Announces Resignation of President and Chief Operating Officer

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.